Ates Tenekeci

11PUBLICATIONS
31CO-AUTHORS
Predictive and prognostic markersCancer therapy (excl. chemotherapy and radiation therapy)Molecular targetsGlycoconjugates
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (11)

|Jan 29, 2026
Prognostic value of the glucose-to-lymphocyte ratio in surgically treated endometrial cancer: a retrospective cohort study.

Furkan Ceylan, Serhat Sekmek, Ateş Kutay Tenekeci

|Jul 21, 2025
Comparative efficacy of adjuvant FOLFOX vs. FLOT following neoadjuvant FLOT in patients with locally advanced gastric cancer.

Furkan Ceylan, Didem Şener Dede, Safa Can Efil

|Jul 15, 2025
Comprehensive management strategies for amivantamab-induced toxicities and review of the literature.

Furkan Ceylan, Gamze Sonmez, Ates Kutay Tenekeci

|Jul 11, 2025
Perioperative Management of Non-Small Cell Lung Cancer in the Era of Immunotherapy.

Ulas Kumbasar, Erkan Dikmen, Zeliha Gunnur Dikmen

|May 28, 2025
Long-Term Outcomes of Patients Undergoing Conversion Surgery After Induction Chemotherapy: Turkish Oncology Group Study.

Furkan Ceylan, Selin Aktürk Esen, Olçun Ümit Ünal

|Mar 28, 2025
Opportunities and Challenges in Antibody-Drug Conjugates for Cancer Therapy: A New Era for Cancer Treatment.

Idil Buyukgolcigezli, Ates Kutay Tenekeci, Ibrahim Halil Sahin

Pageof 2